Clin2
NCT07553377Possibly a fitNot yet recruiting

Digital pill system to support taking acamprosate for alcohol and liver disease

Alcohol Use DisorderAlcohol Associated Liver DiseaseMedications for Alcohol Use DisorderBehavioral MedicineMedication Adherence

Part of Mental health clinical trials.

This study tests a 'digital pill' system that tracks whether you take your alcohol-use medication (acamprosate) and gives you support to stay on track. It might help you stick with your treatment and improve your liver health.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are being treated for alcohol use disorder.
  • You have a diagnosis of moderate to severe alcohol use disorder.
  • You have alcohol-related liver disease as shown by simple blood tests.
  • You are planning to start taking acamprosate, a medicine that helps reduce alcohol cravings.
  • You are not allergic to acamprosate, magnesium, or silver.
  • Your kidneys are working well (no severe kidney disease).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07029529Recruiting· Phase 2
Apremilast for alcohol use disorder

This study tests whether a drug called apremilast can help people who drink heavily reduce their alcohol use. You will take the medication daily for several weeks and attend study visits to track your progress.

New Haven, Connecticut
NCT06489782Recruiting
New approach to test alcohol use disorder medications

This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.

New Haven, Connecticut
NCT06269627Recruiting· Phase 4
Brain activity study for alcohol use treatment

This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.

Bethesda, Maryland
NCT06305624Recruiting
Smartphone app to help people with alcohol-related liver disease stop drinking

This trial tests whether a smartphone program can help people with alcohol-related liver disease reduce or stop drinking. If you have liver disease related to alcohol and have used alcohol in the past 6 months, this app-based support may be for you.

Lansing, Michigan
NCT07325266Recruiting· Phase 2
Testing apremilast for alcohol use disorder

This study tests whether a pill called apremilast can help reduce drinking in people with alcohol use disorder. You'll take the medication and attend regular visits to see how it affects your alcohol cravings and use.

Los Angeles, California
NCT07249554Not yet recruiting· Phase 2
Combination medications for alcohol use disorder

This study tests whether combining two medications—one that helps control cravings and one that affects appetite and reward—can help people reduce or stop drinking alcohol. If you are in treatment for alcohol use disorder收, this may offer a new way to support your recovery.

Havre de Grace, Maryland

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.